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Peroxisomes are unique subcellular organelles which play an indispensable role in several
key metabolic pathways which include: (1.) etherphospholipid biosynthesis; (2.) fatty
acid beta-oxidation; (3.) bile acid synthesis; (4.) docosahexaenoic acid (DHA) synthesis;
(5.) fatty acid alpha-oxidation; (6.) glyoxylate metabolism; (7.) amino acid degradation,
and (8.) ROS/RNS metabolism. The importance of peroxisomes for human health and
development is exemplified by the existence of a large number of inborn errors of
peroxisome metabolism in which there is an impairment in one or more of the metabolic
functions of peroxisomes. Although the clinical signs and symptoms of affected patients
differ depending upon the enzyme which is deficient and the extent of the deficiency, the
disorders involved are usually (very) severe diseases with neurological dysfunction and
early death in many of them. With respect to the role of peroxisomes in metabolism it is
clear that peroxisomes are dependent on the functional interplay with other subcellular
organelles to sustain their role in metabolism. Indeed, whereas mitochondria can oxidize
fatty acids all the way to CO2 and H2O, peroxisomes are only able to chain-shorten
fatty acids and the end products of peroxisomal beta-oxidation need to be shuttled to
mitochondria for full oxidation to CO2 and H2O. Furthermore, NADH is generated during
beta-oxidation in peroxisomes and beta-oxidation can only continue if peroxisomes are
equipped with a mechanism to reoxidize NADH back to NAD+, which is now known to be
mediated by specific NAD(H)-redox shuttles. In this paper we describe the current state
of knowledge about the functional interplay between peroxisomes and other subcellular
compartments notably the mitochondria and endoplasmic reticulum for each of the
metabolic pathways in which peroxisomes are involved.
Keywords: peroxisomes, mitochondria, endoplasmic reticulum, fatty acids, etherphospholipids, genetic diseases,
peroxisomal diseases, metabolism
INTRODUCTION
Eukaryotic cells contain a variety of different subcellular compartments, which differ from one
another in multiple aspects including their biogenesis, enzyme content, and role in metabolism.
Lysosomes, for instance, are primarily involved in the breakdown of macromolecules, whereas
mitochondria are the ultimate site of aerobic metabolism. Peroxisomes perform both catabolic as
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well as anabolic functions. The role of peroxisomes in human
metabolism and their importance for human health and
development has largely been elucidated thanks to the detailed
work on a rare genetic human disease called the cerebro-hepato-
renal syndrome, or Zellweger syndrome (ZS). In patients with
the classical form of ZS, functional peroxisomes are lacking
due to a genetically determined defect in the biogenesis of
peroxisomes. ZS is genetically heterogeneous, which is explained
by the fact that peroxisome biogenesis involves the obligatory
participation of multiple proteins required for the formation,
proliferation, and maintenance of these organelles (Mast et al.,
2010; Waterham and Ebberink, 2012; Hasan et al., 2013; Fujiki
et al., 2014). The proteins involved are called peroxins and are
encoded by PEX genes. Clinically, ZS patients show multiple
abnormalities including cranial facial, neurological, hepatic,
and other aberrations, and usually die early in life. Work
on ZS has resulted in the discovery of the various unique
metabolic functions exerted by peroxisomes which include: (A)
etherphospholipid biosynthesis; (B) fatty acid beta-oxidation; (C)
docosahexaenoic acid synthesis; (D) bile acid synthesis; (E) fatty
acid alpha-oxidation; (F) glyoxylate detoxification; (G) amino
acid metabolism, and (H) ROS/RNS-metabolism.
The essential role of peroxisomes in each of these metabolic
pathways is emphasized by the fact that a variety of genetic
diseases in man has been identified, usually with severe
clinical signs and symptoms, that are caused by mutations in
genes coding for peroxisomal enzymes involved in each of
these metabolic pathways. Table 1 lists the single peroxisomal
enzyme deficiencies identified so far including two recently
identified peroxisomal disorders including fatty acyl-CoA
reductase 1 (FAR1) deficiency (Buchert et al., 2014) and
Peroxisomal Membrane Protein 70 (PMP70/ABCD3) deficiency
(Ferdinandusse et al., 2015).
To fulfill their role in metabolism peroxisomes rely very
much on the interaction with other subcellular organelles. For
instance, beta-oxidation of fatty acids (FAs) in peroxisomes
generates NADH from NAD+. Reoxidation of NADH back to
NAD+, however, relies on the interaction with the cytosol and
subsequently the mitochondrion (see Figure 1). Furthermore,
peroxisomes produce a range of chain-shortened acyl-CoAs
including acetyl-CoA, which can only be fully oxidized to CO2
and H2O in mitochondria and not in peroxisomes. This is due
to the fact that mitochondria contain the citric acid (KREBS)
Abbreviations: ACAA1, peroxisomal 3-ketoacyl-CoA-thiolase1; ACBP,
acyl-CoA binding protein; ACOX, acyl-CoA oxidase; ADHAPS, alkyl-
dihydroxyacetonephosphate synthase; AGPS, alkyl-glyceronephosphate synthase;
AMACR, 2-methyl-acyl-CoA racemase; BAAT, bile acid-CoA: amino acid
N-acyltransferase; BSEP, bile salt export pump; CACT, carnitine/acylcarnitine
translocase; CrAT, carnitineacetyltransferase; CrOT, carnitine octanoyltransferase;
DHA, docosahexaenoic acid; DHAP, dihydroxyacetone phosphate; DHAPAT,
dihydroxyacetonephosphate acyltransferase; DHCA, dihydroxycholestanoic acid;
EPL, etherphospholipid; ER, endoplasmic reticulum; ETF, Electron-Transfer-
Flavoprotein; FA, fatty acid; FAR1, fatty acyl-CoA reductase 1; FAR2, fatty
acyl-CoA reductase 2; G3PDH, GPD1, glycerol-3-phosphate dehydrogenase;
G3P, glycerol-3-phosphate; GNPAT, glycerone-phosphate O-acyltransferase; IDH,
isocitrate dehydrogenase; MUFA/PUFA, mono/poly-unsaturated FA; PMP70,
peroxisomal membrane protein 70; ROS, reactive oxygen species; RNS, reactive
nitrogen species; THCA, trihydroxycholestanoic acid; VLCFA, very long-chain
fatty acid; ZS, Zellweger syndrome.
cycle, which catalyses the degradation of acetyl-CoA to CO2 and
H2O (Figure 1). Also for other metabolic functions, peroxisomes
depend on the interaction with other subcellular organelles. In
this paper we will describe the interactions between peroxisomes
and other subcellular organelles for each of the metabolic
functions of peroxisomes in humans.
(A) Etherphospholipid Biosynthesis
The first major function of peroxisomes in metabolism involves
the synthesis of ether-linked phospholipids (EPLs). In humans
most EPLs occur in their plasmalogen form (Brites et al., 2004).
Peroxisomes are indispensable for etherphospholipid synthesis,
which is due to the fact that the enzyme responsible for the
generation of the ether-bond in EPLs is strictly peroxisomal. The
enzyme involved is alkyl-glyceronephosphate synthase [AGPS;
formally named alkyldihydroxyacetonephosphate synthase
(ADHAPS)] which catalyses the exchange of the acyl-group in
acyl-DHAP for a long-chain alcohol via an ingenious mechanism
to ensure formation of the ether-bond. The two substrates
for AGPS include acyl-DHAP and a long-chain alcohol which
are both synthesized by peroxisomal enzymes including
glycerone-phosphate O-acyltransferase [GNPAT; formally called
dihydroxyacetonephosphate acyltransferase (DHAPAT)] and
one of two peroxisomal acyl-CoA reductases named FAR1 and
FAR2 (Cheng and Russell, 2004). Both AGPS/ADHAPS as well as
GNPAT/DHAPAT are true intra-peroxisomal enzymes targeted
to peroxisomes via the PTS1- and PTS2-import pathways
respectively (Mast et al., 2010; Waterham and Ebberink, 2012;
Hasan et al., 2013; Fujiki et al., 2014; Figure 2A). Both enzymes
are bound to the inner site of the peroxisomal membrane and
form a functional complex (see Figure 2B). On the other hand,
earlier work by Hajra and coworkers (Burdett et al., 1991) had
shown that the situation is different with respect to the third
peroxisomal enzyme involved in etherphospholipid biosynthesis
which is the enzyme acyl-CoA reductase. This enzyme catalyzes
the synthesis of the long-chain alcohol from the corresponding
acyl-CoA ester using NADPH as reductant (Bishop and Hajra,
1981). The enzyme from rat brain (Bishop and Hajra, 1981)
showed high specificity for palmitoyl-CoA (C16:0-CoA),
stearoyl-CoA (C18:0-CoA), and oleoyl-CoA (C18:1-CoA).
Importantly, this acyl-CoA reductase activity was found at the
outer aspect of the peroxisomal membrane, which implies that
the substrates including the acyl-CoA ester plus NADPH are
in the cytosol and not localized in the peroxisomal matrix (see
Figure 2). Most likely, the long-chain alcohol produced in the
acyl-CoA reductase reaction is also released at the cytosolic face
of the peroxisomal membrane (see Figure 2B; Honsho et al.,
2013).
Work by the group of Russell has led to the identification
and characterization of two acyl-CoA reductase isozymes named
FAR1 and FAR2 (Cheng and Russell, 2004). The two FAR
isozymes are ∼58% identical in sequence and are encoded by
two distinct genes with similar exon/intron structures located
on different chromosomes. FAR1 has a broad tissue distribution
and acts on acyl-CoAs that vary in size and saturation suggesting
that this isozyme plays a general role in the synthesis of
fatty alcohols. In contrast, the more narrow tissue distribution
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TABLE 1 | The single peroxisomal enzyme deficiencies and their underlying enzyme and gene defects.
Metabolic pathway involved Peroxisomal disorders Enzyme deficiencies Mutant gene
PEROXISOMAL BETA-OXIDATION
• X-linked adrenoleukodystrophy ALDP ABCD1
• Acyl-CoA oxidase deficiency ACOX1 ACOX1
• D-bifunctional protein deficiency DBP, MFE2, MFP2, D-PBE HSD17B4
• SCPx-deficiency SCPx SCP2
• AMACR deficiency AMACR AMACR
• PMP70-deficiency PMP70 ABCD3
PLASMALOGEN BIOSYNTHESIS
• RCDP Type 2 DHAPAT/GNPAT GNPAT
• RCDP Type 3 ADHAPS/AGPS AGPS
• RCDP Type 4 Acyl-CoA reductase 1 FAR1
• RCDP Type 5 PEX5L PEX5
FATTY ACID ALPHA-OXIDATION
• Refsum disease Phytanoyl-CoA hydroxylase PHYH
BILE ACID SYNTHESIS
• BAAT-deficiency BAAT BAAT
GLYOXYLATE METABOLISM
• Hyperoxaluria Type 1 AGT AGXT
ROS/RNS METABOLISM
• Acatalasaemia Catalase CAT
FIGURE 1 | Schematic diagram showing the functional interplay
between peroxisomes and mitochondria in the beta-oxidation of fatty
acids in peroxisomes. See text for detailed discussion.
and substrate preference of the FAR2 isozyme are indicative
of a more specialized function. Recent work by Fujiki and
coworkers (Honsho et al., 2010, 2013) has revealed that FAR1
is a peroxisomal tail-anchored protein targeted to peroxisomes
via PEX19 (Honsho et al., 2013). Furthermore, the expression of
FAR1 but not FAR2 is posttranslationally regulated. Indeed, FAR1
but not FAR2 is preferentially degraded in response to the cellular
level of plasmalogens (Honsho et al., 2010, 2013). Peroxisomes
have also been found to contain alkyl-DHAP reductase activity
although the bulk of activity is in the endoplasmic reticulum.
The indispensable role of the peroxisomal enzymes GNPAT
(Wanders et al., 1992), AGPS (Wanders et al., 1994), and FAR1
(Buchert et al., 2014) in the formation of etherphospholipids
has become clear from the identification of patients with
genetically determined deficiencies of these three enzymes. In
such patients EPL-synthesis is severely deficient as concluded
from the markedly reduced plasmalogen levels in erythrocytes
from patients (for reviews see Brites et al., 2004; Braverman and
Moser, 2012; Malheiro et al., 2015).
Etherphospholipid Biosynthesis and the Interplay
with Other Organelles
GNPAT and AGPS are true intraperoxisomal enzymes targeted
to peroxisomes via the PTS1- and PTS2-pathways respectively.
Inspection of the two reactions catalyzed by GNPAT and AGPS
reveals that the acyl-CoA ester used by GNPAT to produce
acyl-DHAP, is released in its free acid form in the AGPS-
catalyzed reaction, whereas the CoA unit is released in the
GNPAT catalyzed reaction. Taken together it would make
sense to regenerate the acyl-CoA ester within the peroxisome
via an acyl-CoA synthetase. Peroxisomes contain at least one
truly intraperoxisomal acyl-CoA synthetase called ACSVL1
(SLC27A2), which is a peripheral membrane protein facing
the interior of the peroxisome. The same enzyme also occurs
in the endoplasmic reticulum (ER; Steinberg et al., 1999). If
such a scenario would be true, the formation of alkyl-DHAP
would be as depicted in Figure 2B, the net equation being:
DHAP + long-chain alcohol −→ alkyl-DHAP (see Figure 2C).
The implication of this would be that DHAP and the long-chain
alcohol need to be transported from outside the peroxisome,
whereas alkyl-DHAP needs to be exported from the inside of the
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FIGURE 2 | Etherphospolipid biosynthesis and the important role of peroxisomes and the endoplasmic reticulum. (A) Schematic representation of the
peroxisome and the enzymes and transporters involved in the peroxisomal synthesis of alkyl-DHAP. (B) Schematic representation of the peroxisome and the enzymes
and transporters involved in the peroxisomal synthesis of alkyl-DHAP with special emphasis on the sub-peroxisomal localization of GNPAT and AGPS as peripheral
peroxisomal membrane proteins joined together in a functional complex. (C) Overview of the reactions catalyzed by the three intraperoxisomal enzymes involved in
etherphospholipid synthesis including GNPAT, AGPS, and ACSVL1 (SLC27A2). G3P, glycerol-3-phosphate; DHAP, dihydroxyacetonephosphate; GNPAT,
glyceronephosphate O-acyltransferase; AGPS, alkyl-glyceronephosphate synthase; FAR1, fatty acyl-CoA reductase 1.
peroxisome to the outside. DHAP synthesized from glucose in
the cytosol can move into the peroxisome interior without any
problem if it is true that small solutes up to an Mwof 300 Da,
can move across the peroxisomal membrane freely via PXMP2
(Rokka et al., 2009). However, it has also been claimed that DHAP
is synthesized endogenously from glycerol-3-phosphate (G3P)
as catalyzed by the enzyme glycerol-3-phosphate dehydrogenase
(G3PDH/GPD1). Interestingly, earlier work from Antonenkov
(Antonenkov et al., 1985) has shown that rat liver peroxisomes
do contain G3PDH activity although the true identity of this
enzyme activity has never been resolved definitively. In this
respect it is important to mention the work of Jung et al. in yeast
which revealed dynamic changes in the subcellular distribution
of G3PDH ranging from peroxisomal to cytosolic depending
on the metabolic status of the cells (Jung et al., 2010). Either
way, both G3P and DHAP would qualify for transport across
the peroxisomal membrane via the peroxisomal porine PXMP2
(Rokka et al., 2009).
Since the contribution of peroxisomes to EPL-biosynthesis is
restricted to the formation of alkyl-DHAP, or—at best—alkyl-
G3P, completion of EPL-biosynthesis is very much dependent
upon the interaction with the rest of the cell. In fact, all
subsequent steps in EPL-biosynthesis are catalyzed by ER-bound
enzymes (see Figure 2).
It remains to be established whether the transfer of alkyl-
DHAP and/or alkyl-G3P occurs via the cytosol with the possible
involvement of a binding protein analagous to the binding of
acyl-CoAs by acyl-CoA binding protein (ACBP), or whether
this is mediated via direct interorganellar contact sites between
peroxisomes and the endoplasmic reticulum. Ultrastructural
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studies in the early 1960s had already demonstrated a close
proximity between the smooth ER and peroxisomes (Novikoff
and Shin, 1964). Indeed, transmission electron microscopy
analysis revealed that both organelles appear to be interconnected
by electron-dense intermembrane cross-bridges spanning some
10–15 nm. Additional evidence in favor of the existence of
such cross-bridges came from biochemical studies in which
peroxisomes were isolated from bovine kidney (Zaar et al., 1987).
The identity of the proteins mediating the physical interaction
between peroxisomes and the ER remains to be identified.
(B) Fatty Acid Beta-Oxidation
Like mitochondria, peroxisomes contain a fatty acid beta-
oxidation machinery, which catalyses the stepwise shortening
of acyl-CoAs to produce acetyl-CoA in case of straight-chain
acyl-CoAs and propionyl-CoA when a 2-methyl-branched-chain
acyl-CoA is oxidized. Although the beta-oxidation systems in
peroxisomes andmitochondria are basically identical in chemical
terms and involve four sequential steps of dehydrogenation,
hydration, dehydrogenation again, and thiolytic cleavage, there
are major differences between the two systems which include:
(a.) the four reactions of the mitochondrial and peroxisomal
beta-oxidation pathways are catalyzed by different enzymes
each encoded by a distinct gene; (b.) the mitochondrial
enzymes catalyzing the first step of beta-oxidation are FAD-
dependent dehydrogenases, which feed their electrons into the
respiratory chain via the Electron-Transfer-Flavoprotein (ETF)
cycle, whereas the corresponding peroxisomal enzymes are FAD-
dependent acyl-CoA oxidases donating their electrons directly
to molecular oxygen (O2); (c.) fatty acids are transported across
the peroxisomal membrane as acyl-CoAs, or as free fatty acids,
whereas fatty acids are transported across the mitochondrial
membrane as acylcarnitine esters mediated by the carnitine
cycle via the concerted action of carnitine palmitoyl transferase
1 (CPT1), carnitine acylcarnitine translocase (CACT), and
carnitine palmitoyl transferase 2 (CPT2); (d.) carnitine does
not play a role in the uptake of fatty acids into peroxisomes
but is required for the transport of the end products of
peroxisomal beta-oxidation to mitochondria for full oxidation
to CO2 and H2O, which requires the active participation of the
citric acid cycle and the mitochondrial oxidative phosphorylation
system (respiratory chain); (e.) mitochondria are able to degrade
FAs to CO2 and H2O, whereas peroxisomes can only chain-
shorten fatty acids to acetyl-CoA, propionyl-CoA, and different
medium-chain acyl-CoAs, which all need to be transferred to
mitochondria for full oxidation to CO2 and H2O, and (f.)
both peroxisomes and mitochondria are equipped with auxiliary
enzymes for the oxidation of unsaturated fatty acids and 2R-
methyl branched chain FAs.
Peroxisomal beta-oxidation of the various acyl-CoA esters is
mediated by two acyl-CoA oxidases, two bifunctional proteins,
and two thiolases (Figure 3A). Much of our knowledge about
the physiological roles of the different enzymes involved has
come from studies in human patients in whom one of
the peroxisomal beta-oxidation enzymes is deficient due to
mutations in the structural genes encoding these proteins (see
Figure 3B, Table 1) as well as in mutant mice. Taken all
data together, current knowledge holds that acyl-CoA oxidase
1 (ACOX1) is the main enzyme involved in the oxidation
of VLCFAs and dicarboxylic acids (DCAs), whereas ACOX2,
also called branched-chain acyl-CoA oxidase (BCOX), is the
prime oxidase handling the CoA esters of pristanic acid and
di- and trihydroxycholestanoic acid (DHCA/THCA) (Vanhove
et al., 1993). The second and third steps of beta-oxidation
in peroxisomes are catalyzed by two multifunctional proteins
alternatively named L- and D-bifunctional protein (LBP and
DBP), peroxisomal multifunctional enzyme type 1 and 2 (MFE1
and MFE2), multifunctional protein 1 and 2 (MFP1 and MFP2),
and L- and D-peroxisomal bifunctional enzyme (L-PBE and
D-PBE) which have been purified, characterized and cloned
from various sources (Dieuaide et al., 1996; Leenders et al.,
1996; Dieuaide-Noubhani et al., 1997; Jiang et al., 1997; Qin
et al., 1997a,b). With respect to their physiological role, it is
now clear that the D-specific enzyme as encoded by HSD17B4
catalyzes the hydration and subsequent dehydrogenation of most
peroxisomal beta-oxidation substrates including the enoyl-CoA
esters of VLCFAs, pristanic acid and DHCA and THCA, whereas
the L-specific enzyme appears to handle the dicarboxylic enoyl-
CoA esters specifically (see Figure 4; Houten et al., 2012). Finally,
with respect to the two thiolases, work on the isolated enzymes
(Antonenkov et al., 1997; Wanders et al., 1997) as well as Sterol
Carrier Protein X (SCPx)-deficient patients (Ferdinandusse et al.,
2006) and mutant mice (Seedorf et al., 1998; Kannenberg et al.,
1999) has shown that both peroxisomal 3-ketoacyl-CoA-thiolase
1 (ACAA1; pTH1) and SCPx (pTH2) encoded by ACAA1 and
SCP2, respectively, are involved in the oxidation of VLCFAs,
whereas the 3-ketoacyl-CoA esters of pristanic acid, DHCA and
THCA are solely cleaved by SCPx. The redundancy of the two
thiolases with respect the oxidation of VLCFAs may explain why
peroxisomal 3-ketoacyl-CoA-thiolase1 (ACAA1)-deficiency has
not been identified sofar.
Peroxisomes are not only able to oxidize saturated FAs but
also catalyze the oxidation of certain mono- and polyunsaturated
FAs as well as 2-(R)-methyl branched-chain FAs and 2-hydroxy-
FAs (see Wanders and Waterham, 2006; Van Veldhoven, 2010
for reviews). To this end, peroxisomes contain a set of so-called
auxiliary enzymes including enoyl-CoA isomerase(s) and 2,4-
dienoyl-CoA reductase(s) to remove the double bond present in
mono- and polyunsaturated acyl-CoAs, respectively. It should
be noted that it is currently unknown which mono- and/or
polyunsaturated FAs (MUFA/PUFA) are solely oxidized in
peroxisomes except from tetracosahexaenoic acid (C24:6 n-3) as
discussed under (C.).
The peroxisomal branched-chain acyl-CoA oxidase ACOX2
only reacts with 2-methyl branched-chain acyl-CoAs if the
methyl-group is in the 2(S)-position (Van Veldhoven et al.,
1996). For DHCA and THCA, which are produced from
cholesterol in the liver, this is a potential problem because the
methyl-group in the carboxy-terminal side chain of DHCA and
THCA has the 2(R)- rather than 2(S)- configuration which thus
prohibits beta-oxidation. This problem is resolved by an enzyme
called 2-methyl-acyl-CoA racemase (AMACR), located both in
peroxisomes and mitochondria, which is able to convert 2(R)-
acyl-CoAs into 2(S)-acyl-CoAs (Schmitz et al., 1997; Amery
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FIGURE 3 | Peroxisomes, fatty acid beta-oxidation and the human deficiencies of peroxisomal beta-oxidation. (A) Schematic diagram depicting the
substrates known to be oxidized in peroxisomes exclusively and the transporters and enzymes involved in their degradation (see text for detailed information). (B)
Schematic diagram depicting the substrates known to be oxidized in peroxisomes exclusively and the transporters and enzymes involved in their degradation and the
human deficiencies in the peroxisomal beta-oxidation pathway so far identified (see text for more information).
et al., 2000; Ferdinandusse et al., 2000; Kotti et al., 2000). The
same enzyme is also required to convert the 2(R)-methyl-group
in pristanic acid (2,10,14,16-tetramethylpentadecanoic acid) as
derived from phytanic acid into the 2(S)-position (Figure 3A).
Peroxisomal Beta-Oxidation and the Interplay with
Mitochondria
As already eluded to before, peroxisomes are dependent on other
organelles for several of their metabolic functions. The interplay
withmitochondria is especially important for further metabolism
of the end-products of beta-oxidation in peroxisomes
including: (1.) NADH; (2.) acetyl-CoA; (3.) propionyl-
CoA, and (4.) a variety of acyl-CoAs chain-shortened in
peroxisomes.
• NADH reoxidation: beta-oxidation in peroxisomes can only
continue if the NADH formed in peroxisomes is reoxidized
to NAD+. Ideally, a carrier system in the peroxisomal
membrane catalyzing the exchange between NADH in
the peroxisome and NAD+ in the cytosol would serve
this purpose. However, since such a system appears to
be lacking at least in higher eukaryotes, the existence of
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FIGURE 4 | Schematic diagram depicting the peroxisomal enzymes involved in the degradation of very long-chain fatty acids (VLCFAs), pristanic acid,
di- and trihydroxycholestanoic acid, and long-chain dicarboxylic acids. See text for detailed information.
FIGURE 5 | Functional interplay between peroxisomes and mitochondria with respect to the reoxidation of NADH produced within the peroxisomal
beta-oxidation system. (A) S. cerevisiae (see text for detailed information). (B): H. sapiens. PYR, pyruvate; LAC, lactic acid; LDH, lactate dehydrogenase; GOT,
glutamate oxaloacetate transaminase; ASP, L-aspartate, GLUT, L-glutamate; 2OG, 2-oxoglutarate; MDH1, mitochondrial malate dehydrogenase.
metabolite-based redox shuttles has been proposed analogous
to the well-known malate/aspartate shuttle in mitochondria
(see Figure 1). In baker’s yeast (S. cerevisiae) the existence of
a peroxisomal NAD(H)-redox shuttle has been demonstrated
and involves a malate/oxaloacetate based redox shuttle for
reoxidation of peroxisomal NADH (Figure 5A). In higher
eukaryotes, however, including humans, the identity of the
peroxisomal NAD(H)-redox shuttle has not been resolved
definitively although evidence in favor of the existence of
a lactate/pyruvate-based redox shuttle has been provided by
Baumgart et al. (1996), at least in rat liver peroxisomes
(see Figure 5B). Whatever the precise identity of the
peroxisomal NAD(H)-redox shuttle, ultimate reoxidation of
peroxisomal NADH back into NAD+, can only be achieved in
mitochondria. The same is true for the NADHproduced in the
cytosol from glucose upon its conversion into pyruvate during
glycolysis. Reoxidation of cytosolic NADH is mediated by one
of two NAD(H)-redox shuttles including the malate/aspartate
and glycerol-3-phosphate/dihydroxyacetonephosphate redox
cycles.
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FIGURE 6 | Functional interplay between peroxisomes and
mitochondria in the oxidation of C26:0. See text for detailed information.
ALDP, adrenoleukodystrophy protein; TE, acyl-CoA thioesterase; CrOT,
carnitine octanoyltransferase; CrAT, carnitine acetyltransferase; CACT,
mitochondrial carnitine: acylcarnitine translocase.
• Reduction of peroxisomal NADP back into NADPH: as for
the reoxidation of peroxisomal NADH, redox shuttles have
been proposed also for the reduction of NADP as produced
in the dienoyl-CoA reductase reaction back into NADPH.
In the yeast S. cerevisiae there is strong evidence in favor
of the existence of a peroxisomal 2-oxoglutarate/(iso) citrate
NADP(H)-redox shuttle (van Roermund et al., 1998) next
to a similar shuttle identified earlier in mitochondria. These
two shuttle systems require the active participation of NADP-
linked isocitrate dehydrogenases (IDHs) in mitochondria,
peroxisomes and the cytosol respectively. These three
activities are catalyzed by three distinct enzymes each
encoded by a different gene, at least in S. cerevisiae.
In higher eukaryotes, however, it appears that there are
only two genes coding for NADP-linked IDHs, one in
mitochondria, and the other one in peroxisomes, and
the cytosol. Detailed work by Yoshihara and coworkers
has shown that the bulk of the peroxisomal/cytosolic
IDH-activity is actually peroxisomal (>90%), at least in
hepatocytes (Yoshihara et al., 2001). As shown by Geisbrecht
and Gould, the peroxisomal/cytosolic NADP-linked IDH is
equipped with a true PTS1 sequence (Geisbrecht et al.,
1999).
• Mitochondria as ultimate site of oxidation of the different
acyl-CoA esters produced in peroxisomes: the acetyl-CoA,
propionyl-CoA, and medium-chain acyl-CoAs produced in
peroxisomes, ultimately require the mitochondrial citric
FIGURE 7 | Schematic diagram showing the key role of peroxisomes in
the formation of C22:6 n-3. Doxosahexaenoic acid is synthesized from
C18:3 n-3 which first undergoes a number of elongation and desaturation
steps in the endoplasmic reticulum to produce C24:6-CoA which is then
transported to the peroxisome and imported via a mechanism not yet resolved.
Within peroxisomes C24:6-CoA undergoes one cycle of beta-oxidation to
produce the corresponding C22:6-CoA which can then be exported out of the
peroxisome for subsequent incorporation into lipids in the endoplasmic
reticulum or may undergo additional sequential rounds of oxidation in
peroxisomes and mitochondria. See text for more detailed information.
acid cycle and oxidative phosphorylation system for full
oxidation to CO2 and H2O. Shuttling of the different
CoA-esters can occur via two mechanisms including: (1.)
the carnitine-mediated pathway, and (2.) the free-acid
pathway. The first pathway requires conversion of the
different acyl-CoA species into acylcarnitines in peroxisomes.
To this end, peroxisomes contain two distinct carnitine-
acyltransferases, named carnitine-acetyltransferase (CrAT)
and carnitine-octanoyltransferase (CrOT) reactive with short
and medium-chain acyl-CoAs respectively. The different
acylcarnitines are then exported out of the peroxisome via
some unknown mechanism, and enter the mitochondrion
via the mitochondrial carnitine/acylcarnitine translocase
(CACT) followed by the reconversion of the acylcarnitines
esters back into the corresponding acyl-CoAs followed by
further degradation to CO2 and H2O. The alternative,
free-acid route first involves cleavage of the acyl-CoA
esters by one of a variety of different thioesterases that
have been identified in peroxisomes (see Hunt et al.,
2012 for review). Next, the free acids move out of the
peroxisome probably through the porine (PXMP2) identified
by Hiltunen and coworkers (see Rokka et al., 2009;
Antonenkov and Hiltunen, 2012 for review) and then enter
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the mitochondrion most likely in their protonated form.
Mitochondria contain both short-chain as well as medium-
chain acyl-CoA synthetase activities to reactivate the free acids
back into the corresponding acyl-CoAs followed by oxidation
either directly (acetyl-CoA) or indirectly (propionyl-CoA and
medium-chain acyl-CoAs). Figure 6 shows how this works
out for C26:0. It remains to be established whether the
transfer of metabolites from peroxisomes to mitochondria
occurs via simple diffusion through the cytosol, or whether
this is mediated through direct interorganellar contacts
between peroxisomes and mitochondria. Close proximity
between peroxisomes and mitochondria has been observed
in intrastructural studies already many years ago (Hicks and
Fahimi, 1977). In addition, there is biochemical evidence for
direct peroxisome-mitochondrion interactions from density
gradient centrifugation analyses (Islinger et al., 2006). Very
recently, a genome-wide localization study of peroxisome-
mitochondria interactions in yeast has led to the identification
of a direct interaction between Pex11, a membrane-bound
peroxin involved in peroxisome division and proliferation,
and the mitochondrial ERMES complex. Interestingly, PEX11
was found to physically interact with Mdm34 to establish
the contact between peroxisomes and mitochondria (see
Schrader et al., 2015 for recent review). Tethering of both
organelles is supposed to enhance metabolism by reducing
the distance for efficient transport of metabolites from the
peroxisome to the mitochondrion. Mammalian cells, however,
lack ERMES so that another tethering complex is supposed
to perform a similar function in higher eukaryotes, including
humans.
(C) Docosahexaenoic Acid (C22:6 n-3)
Synthesis
DHA (C22:6 n-3) is the most important n-3 PUFA and is the
major PUFA in adult mammalian brain and retina. A deficiency
of DHA can lead to memory loss, learning disabilities and
impaired visual acuity (Jump, 2002). DHA is synthesized from
dietary linolenic acid (C18:3 n-3) in the endoplasmic reticulum
via a series of elongation and desaturation reactions. This
pathway requires that C22:5 n-3 would be desaturated at position
4 by an acyl-CoA-dependent delta4-desaturase to form C22:6
n-3. Several studies have shown that mammals do not possess
such a delta4-desaturase. Instead, a 24-carbon n-3 fatty acid is
first synthesized which is then desaturated at position six to
produce C24:6 n-3 followed by one round of beta-oxidation in
the peroxisome with C22:6 n-3 as final product (see Figure 7).
Interestingly, some of the enzymes involved in the beta-oxidation
of C24:6 n-3-CoA have been identified and include the straight-
chain acyl-CoA oxidase (ACOX1) and D-bifunctional protein
(Su et al., 2001; Ferdinandusse et al., 2003). The C22:6-CoA
produced in peroxisomes may either undergo continued beta-
oxidation in peroxisomes and subsequently in mitochondria or
be exported out of the peroxisome for incorporation into lipids in
the endoplasmic reticulum. The exact mechanism by which DHA
is exported from the peroxisomes either as coenzyme A ester or
as free acid has not been deduced sofar.
(D) Bile Acid Synthesis
Peroxisomes also play an indispensable role in the biosynthesis
of the primary bile acids cholic acid and chenodeoxycholic acid.
The underlying basis for the obligatory role of peroxisomes in
bile acid formation, resides in the fact that the two bile acid
intermediates, i.e., 3alpha, 7alpha-dihydroxy-5beta-cholestanoic
acid (DHCA) and 3alpha, 7alpha, 12alpha-trihydroxy-5beta-
cholestanoic acid (THCA) undergo beta-oxidative chain
shortening in peroxisomes with propionyl-CoA as one product
and chenodeoxycholoyl-CoA and choloyl-CoA as the respective
other products of beta-oxidation (see Figure 8). The enzymes
catalyzing the formation of DHCA and THCA respectively
are localized in different subcellular compartments including
the cytosol, endoplasmic reticulum, and mitochondrion
(CYP27A1) (see Russell, 2003 for review). Activation of
DHCA and THCA produced by the mitochondrial enzyme
CYP27A1 most likely occurs by the ER enzyme bile acid-
CoA ligase (BACL) encoded by SLC27A5 (Wheeler et al.,
1997; Falany et al., 2002) after which the two CoA-esters
of DHCA and THCA enter the peroxisome. The recent
identification of PMP70 deficiency in a patient with markedly
elevated DHCA and THCA levels in plasma supported
by additional studies in the Pmp70(-/-/) mouse has led to
the conclusion that the peroxisomal half-ABC-transporter
PMP70 (ABCD3) catalyzes the import of these acyl-CoAs
into peroxisomes (Ferdinandusse et al., 2015). The actual
beta-oxidation of DHC-CoA and THC-CoA is catalyzed by
the enzymes ACOX2, D-bifunctional protein, and peroxisomal
thiolase-2 (SCPx) (see Figure 4). Subsequently, the two acyl-
CoAs are converted into the corresponding taurine and/or
glycine esters by the enzyme bile acid-CoA: amino acid N-
acyltransferase (BAAT). Work by Faber and coworkers has
shown that BAAT is a strictly peroxisomal enzyme indicating
that tauro/glycocholate and tauro/glycochenodeoxycholate are
the true end products of peroxisomal bile acid metabolism
(Pellicoro et al., 2007). The tauro/glycoconjugates of cholic
acid and chenodeoxycholic acid are then exported from the
peroxisome interior via some unknown mechanism into the
cytosol followed by the rapid excretion from the hepatocytes into
bile via BSEP (ABCB11) localized in the canulicular membrane
(Figure 8).
(E) Phytanic Acid Alpha-Oxidation
3-methyl-FAs cannot be beta-oxidized right away simply because
the methyl-group at the 3-position prohibits beta-oxidation. In
order to allow oxidation of 3-methyl-FAs, these FAs first need
to undergo one cycle of alpha-oxidation thereby converting
the 3-methyl-FA into a 2-methyl-FA which can then be beta-
oxidized (Wanders et al., 2011b). Alternatively, 3-methyl-FAs
may be oxidized via the omega end so that phytanic acid is
actually chain-shortened from the omega-end (see Wanders
et al., 2011a for review). The best known FA undergoing alpha-
oxidation, is phytanic acid (3,7,11,14-tetramethylhexadecanoic
acid) as concluded from observations on a rare disease called
Refsum disease in which alpha-oxidation is blocked due to a
genetic deficiency of the enzyme phytanoyl-CoA 2-hydroxylase
encoded by PHYH. Phytanic acid is strictly derived from
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FIGURE 8 | Schematic diagram showing the unique and important role
of peroxisomes in the formation of the primary bile acids cholic acid
and deoxycholic acid. See text for detailed information.
dietary sources and cannot be synthesized de novo. Although
not well-studied, the general notion is that phytanic acid is
transported throughout the body via the blood in its free as
well as esterified form. Indeed, in plasma phytanic acid has
been identified in triglycerides but also in other lipid species.
According to Wierzbicki et al. (1999) most of the phytanic
acid in Refsum disease patients is present in the LDL-fraction.
Hydrolysis of LDL-particles after receptor mediated uptake into
cells within lysosomes would then release the phytanic acid
into the cytosol. The fact that there are multiple acyl-CoA
synthetases able to convert phytanic acid into phytanoyl-CoA
(see Wanders et al., 2011b for review) would ensure rapid
formation of phytanoyl-CoA in the extra-peroxisomal space.
This implies that phytanoyl-CoA is the most likely substrate to
be transported across the peroxisomal membrane. Based on our
own recent work in a patient with a genetic defect in ABCD3
coding for PMP70 as well as studies in amutantAbcd3(-/-) mouse
model we conclude that PMP70 (ABCD3) catalyzes the uptake of
phytanoyl-CoA into peroxisomes (Ferdinandusse et al., 2015; see
Figure 9).
Once inside the peroxisome interior, phytanoyl-CoA is
hydroxylated by the enzyme phytanoyl-CoA 2-hydroxylase first
identified by Mihalik et al. (1995) to produce 2-hydroxy-
phytanoyl-CoA. The enzyme involved belongs to the group of
2-oxoglutarate-dependent dioxygenases and the hydroxylation of
the substrate is driven by 2-oxoglutarate and molecular oxygen
with succinate and CO2 as products (Mukherji et al., 2003).
Subsequently, the enzyme 2-hydroxyacyl-CoA lyase (HACL)
cleaves 2-hydroxyphytanoyl-CoA, and a range of other 2-
hydroxy acyl-CoAs in fact, between the first and second carbon
atom to produce formyl-CoA plus the aldehyde pristanal in
case of phytanic acid alpha-oxidation (Foulon et al., 2005). This
aldehyde is then converted into the corresponding acid (pristanic
acid). Available evidence holds that peroxisomes do contain
aldehyde dehydrogenase activity as shown for pristanal by Jansen
et al. (2001). The true identity of this enzyme activity has not
been settled definitively. For humans it has been suggested
that FALDH-V, a truncated splice product produced from the
ALDH3A2 gene, is directed to peroxisomes (Ashibe et al., 2007).
The bulk of FALDH-activity produced from the ALDH3A2
gene, however, is located in the endoplasmic reticulum (ER).
Whether FALDH-V is truly the enzyme responsible for
the pristanal dehydrogenase activity in peroxisomes remains
doubtful, however, for various reasons including the fact that
FALDH-V appears to be a membrane-bound enzyme with its
catalytic domain exposed to the cytosol, whereas the peroxisomal
pristanal dehydrogenase activity is catalyzed by a soluble matrix
enzyme (Jansen et al., 2001). Furthermore, phytanic acid alpha
oxidation is fully normal in patients suffering from Sjögren
Larsson syndrome (SLS) caused by mutations in the ALDH3A2
gene. In line with these results, phytanic acid does not accumulate
in SLS-patients. Figure 9 depicts the organization of the alpha-
oxidation system in peroxisomes as envisaged right now with
phytanoyl-CoA 2-hydroxylase, HACL, and also the putative
pristanal dehydrogenase all localized in the matrix of the
peroxisome. The alpha-oxidation machinery can only work
efficiently if the NADH produced in the aldehyde dehydrogenase
reaction is reoxidized back to NAD+ as described above.
Furthermore, constant supply of 2-oxoglutarate is required,
coupled to the removal of succinate. Both 2-oxoglutarate and
succinate can probably move freely through the peroxisomal
membrane via the peroxisomal porine PXMP2. Since succinate is
a 4-carbonmolecule, whereas 2-oxoglutarate has 5-carbon atoms,
reconversion of succinate back into 2-oxoglutarate can only be
achieved via one of the carboxylases or some other mechanism.
A possible role for one of the four known carboxylases, including
pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA
carboxylase, and methylmalonyl-CoA carboxylase is hard to
envisage. However, conversion of succinate back into 2-
oxoglutarate can also occur in themitochondrion by using part of
the citric acid cycle and in particular the citrate synthase reaction
which can turn a C4-molecule like oxaloacetate into the 6-carbon
molecule citrate. The mechanism would then be that succinate
enters the mitochondrion via the mitochondrial dicarboxylate
carrier and is converted back into 2-oxoglutarate via the
concerted action of succinate dehydrogenase, fumarase, malate
dehydrogenase, citrate synthase, and NAD-linked isocitrate
dehydrogenase followed by export of 2-oxoglutarate via the
mitochondrial carrier specific for 2-oxoglutarate (see Figure 9).
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FIGURE 9 | Functional interplay between mitochondria and peroxisomes in the alpha-oxidation of phytanic acid. See text for detailed information.
With respect to one of the other products of alpha-oxidation,
i.e., formyl-CoA, the current notion holds that formyl-CoA
is rapidly hydrolyzed spontaneously to produce free CoASH
and formic acid (Croes et al., 1997). Formic acid can be
degraded via two pathways including: (1.) a catalase mediated
pathway in which catalase operates in the peroxidative mode
and (2.) via the folate-dependent pathway (Tephly, 1991).
Finally, the CoA released from formyl-CoA could be used to
convert pristanic acid to pristanoyl-CoA as described above. In
fact, peroxisomes do contain pristanoyl-CoA synthetase activity
which is probably catalyzed by the enzyme ACSVL1 (SLC27A2)
as already mentioned above. Figure 9 shows the final scheme in
which the considerations above have been incorporated and used
to construct a feasible model.
(F) Glyoxylate Detoxification
In humans the enzyme alanine glyoxylate aminotransferase
(AGXT) is the principal enzyme involved in the detoxification
of glyoxylate, is strictly peroxisomal in human liver (Danpure
and Jennings, 1986) and a deficiency of this enzyme causes
hyperoxaluria type 1 (Danpure et al., 1987) which in its
extreme form may be lethal due to the accumulation of
calcium oxalate in multiple tissues including the kidneys,
liver, and heart (see Salido et al., 2012 for review). The
product of the AGXT reaction in peroxisomes is pyruvate
which needs to be reconverted into alanine via different
transaminases localized in the cytosol or degraded in the
mitochondrion via the enzyme pyruvate dehydrogenase,
which again shows the interaction of peroxisomes with
multiple subcellular compartments including the cytosol
and the mitochondrion in the case of glyoxylate metabolism
(Figure 10; Salido et al., 2012). Glycine is further metabolized
in mitochondria and broken down via the glycine cleavage
enzyme which is made up of four different proteins, named
P-, T-, H-, and L-protein (see Figure 10; Kikuchi et al., 2008 for
review).
It should be noted that much remains to be learned about the
metabolic precursors of glyoxylate although glycolate is definitely
one of the major sources of glyoxylate with the peroxisomal
enzyme 2-hydroxy acid oxidase (HAO1; alternative named:
glycolate oxidase) as the enzyme responsible for the conversion
of glycolate to glyoxylate (Vignaud et al., 2007). Other known
sources of glyoxylate are hydroxyproline (Knight et al., 2006) and
glycine.
(G) Amino Acid Metabolism
Peroxisomes also play an indispensable role in the degradation
of a range of amino acids, notably the D-amino acids. Indeed,
mammalian tissues contain at least two different degradative
enzymes that are stereospecific for D-amino acids including
D-amino acid oxidase (DAO; also known as DAAO) and D-
aspartate oxidase (DDO; also known as DASPO). Both DAO
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FIGURE 10 | The detoxification of glyoxylate in peroxisomes as catalyzed by the enzyme alanine glyoxylate aminotransferase (AGXT).
and DDO are FAD-linked flavoproteins able to catalyze the
oxidative deamination of D-amino acids to produce H2O2,
ammonia, and the corresponding 2-oxoacid. The DAO gene
product displays a broad substrate specificity and reacts with
a range of neutral and basic D-amino acids including D-
serine, D-alanine, and others (Krebs, 1935; Dixon and Kleppe,
1965). The other oxidase (DDO) is highly specific for acidic
D-amino acids such as D-aspartate and D-glutamate but also
reacts with N-methyl-D-aspartate acid. Mammalian DAO and
DDO are presumed to regulate the levels of several endogenous
and exogenous D-amino acids including D-serine and D-
aspartate in various organs notably the brain. D-serine for
instance binds to the glycine binding site of the N-methyl-
D-aspartate (NMDA) receptor and potentiates glutamatergic
neurotransmission in the central nervous system. Several lines
of evidence suggest that D-serine plays an important role in
the regulation of brain functions by acting as co-agonist for the
NMDA receptor and perturbations in D-serine in the nervous
system have recently been implicated in the pathophysiology of
various neuropsychiatric disorders (see Katane et al., 2015 for
references). Recent studies have also shown that D-aspartate acts
as signaling molecule in nervous and neuroendocrine systems
at least in part by binding to the NMDA receptor and, thus
plays an important role in the regulation of brain function
(Katane and Homma, 2011; Errico et al., 2012; Ota et al., 2012).
Furthermore, peroxisomes, at least in humans, are the sole
site of L-pipecolic acid oxidase activity which is a metabolite
derived from lysine (Wanders et al., 1988; Mihalik et al., 1989).
There is currently very little information in literature on the
functional interplay between peroxisomes and other subcellular
compartments in the oxidation of the various amino acids in
humans is concerned.
(H) ROS/RNS-Metabolism
In line with its name, the peroxisome also plays a major
role in cellular ROS/RNS-metabolism. Indeed, peroxisomes
contain a large number of ROS-producing enzymes of which
the acyl-CoA oxidases are the most abundant being present
in virtually all peroxisomes independent of the tissue and
cell type involved. Other H2O2 producing oxidases include
D-amino acid oxidase (DAO), D-aspartate oxidase (DDO),
L-pipecolate oxidase (PIPOX), 2-hydroxy acid oxidases (HAO),
polyamine oxidase, and xanthine oxidase. Furthermore, the
inducible form of NOS (NOS2) is localized in peroxisomes
(for review see Schrader and Fahimi, 2006; Antonenkov et al.,
2010; Fransen et al., 2012; Nordgren and Fransen, 2014;
Lismont et al., 2015). In addition, peroxisomes contain a large
network of enzymatic and also non-enzymatic antioxidants
that protect the organelle from oxidative damage. The main
antioxidant enzymes include thioredoxin 2(TRX2), thioredoxin
reductase (TXNRD2), the glutaredoxins 2 (GLRX2), and 5
(GLRX5), the peroxiredoxins 3 (PRDX3), and 5 (PRDX5),
GSH peroxidase 1 (GPX1), oxidized glutathione (GSSG)
reductase (GSR), and the copper/zinc (SOD1)- and manganese
(SOD2)-containing SODs (see Lismont et al., 2015 for review).
Recent work by Fransen and coworkers (Wang et al., 2013)
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has shown that also with respect to ROS/RNS-metabolism
there is marked functional interplay between peroxisomes
and other subcellular organelles, notably mitochondria
(Wang et al., 2013).
CONCLUDING REMARKS
Peroxisomes play a crucial role in cellular metabolism as
exemplified by the different inborn errors of metabolism caused
by a deficiency of one of the peroxisomal enzymes (Table 1)
as reviewed in this paper. It is also fully clear that the
metabolic capabilities of peroxisomes are very much dependent
on the functional interplay with other organelles, notably the
mitochondrion and endoplasmic reticulum. Although much
has been learned about the functional organization of the
peroxisome in terms of the enzymes involved and the end-
products of peroxisomal metabolism, there are still substantial
gaps in our knowledge about peroxisome metabolism. These
include the question how substrates and products of peroxisome
metabolism are transported across the peroxisomal membrane,
especially since PXMP2 only allows passage of small molecules
with an Mw < 300 (Antonenkov and Hiltunen, 2012). One
other area which has remained relatively unexplored involves
the mechanism of transfer of the end products of peroxisome
metabolism from the peroxisome to other organelles like the
mitochondrion and ER. It is gratifying to see that several
recent reports are beginning to shed light on the mechanisms
involved in the physical interaction between individual organelles
and the proteins involved. This is especially true for the
peroxisome-mitochondrion association with the identification
of PEX11 and its interaction with the ERMES complex
(Mattiazzi Usaj et al., 2015; see Schrader et al., 2015 for
review).
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